gliclazide has been researched along with Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, S; Huang, K; Ma, J; Ma, Y; Shen, S; Wang, J; Wu, Y; Zhou, M | 1 |
1 other study(ies) available for gliclazide and Sarcoma
Article | Year |
---|---|
Blocking autophagy enhances the apoptotic effect of 18β-glycyrrhetinic acid on human sarcoma cells via endoplasmic reticulum stress and JNK activation.
Topics: Animals; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Endoribonucleases; Enzyme Activation; Female; G1 Phase; Glycyrrhetinic Acid; Humans; JNK Mitogen-Activated Protein Kinases; Mice, Inbred BALB C; Mice, Nude; Protective Agents; Protein Serine-Threonine Kinases; Resting Phase, Cell Cycle; Sarcoma; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |